Focused on rare liver disease therapies, this biopharma company reported a significant insider sale amid strong one-year stock gains.

Building a company from the ground up is a risky (but hopefully rewarding) endeavor for founders. In exchange for the founders’ efforts and devotion to the success of the company, the founders take a ...

This clinical-stage biotech specializing in blood disorders reported a notable insider sale amid strong recent stock performance.

COOL COMPANY Ltd. (“CoolCo” or the “Company”) advised today that, pursuant to the Company’s Long-Term Incentive Program (the “LTIP”), certain outstanding restricted stock units (“RSUs”) ...

Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Legal & General ( (GB:LGEN)) has shared ...

Imagion Biosystems Ltd. ( ($AU:IBX) ) just unveiled an announcement. Imagion Biosystems has issued 1.4 million fully paid ordinary shares at a ...

OpenAI last fall set aside an employee stock grant pool worth 10% of the company, which was valued in October at $500 billion ...

Winston explained that stock vesting is when compensation to Turner for his services to Li-Ning actually occurred. “Upon vesting,” the judge wrote, “Turner received the Stock as payment for his ...